Showing results (41-50 of 250) with videos related to

Sort By:
Pageof 25
Acta Oncologica (Stockholm, Sweden)|July 2, 2010
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancerAdrian S Ishkanian, Gaetano Zafarana, John Thoms, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2019
TP53 and Prognosis in mCRPC Survival: Biology or Coincidence?Richard J Rebello, Christoph Oing, Silke Gillessen, et al.
Canadian Medical Association Journal|May 1, 1982
Appraisal of pediatric cardiopulmonary resuscitationR M Friesen, P Duncan, W A Tweed, et al.
Nature Communications|February 7, 2020
Divergent mutational processes distinguish hypoxic and normoxic tumoursVinayak Bhandari, Constance H Li, Robert G Bristow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2011
The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombinationHelen Zhao, Kaisa R Luoto, Alice X Meng, et al.
Canadian Medical Association Journal|August 6, 1977
Resuscitation from cardiopulmonary arrest during accidental hypothermia due to exhaustion and exposureG Bristow, R Smith, J Lee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2007
Homologous recombination and prostate cancer: a model for novel DNA repair targets and therapiesRobert G Bristow, Hilmi Ozcelik, Farid Jalali, et al.
Current Problems in Cancer|June 24, 2017
Targeting DNA repair for precision radiotherapy: Balancing the therapeutic ratioOsman Mahamud, Jonathan So, Melvin L K Chua, et al.
Bioinformatics (Oxford, England)|June 13, 2017
Comparison of pre-processing methods for Infinium HumanMethylation450 BeadChip arrayYu-Jia Shiah, Michael Fraser, Robert G Bristow, et al.
Urologic Oncology|April 29, 2014
Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancerMichael Fraser, Alejandro Berlin, Robert G Bristow, et al.
Pageof 25